NDC11 63323046431
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 63323-0464-31 | 63323-0464 |
| 63323-464-31 | 63323-464 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SENSORCAINE MPF | BUPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | b6bfc04a-1868-4630-9ca1-8c027af97ce3 | 2024-11-18 | Boxed warning, Warnings, Adverse reactions | 63323-464 |
| SENSORCAINE MPF | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | eb6d8fee-def4-4c96-9972-695e8cea8ea8 | 2024-10-15 | Boxed warning, Warnings, Adverse reactions | 63323-464-31 63323-464 63323046431 |
| Sensorcaine MPF | BUPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | e700eb7b-8b14-49c9-96b2-331f18776e45 | 2023-05-12 | Boxed warning, Warnings, Adverse reactions | 63323-464 |
| SENSORCAINE MPF | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | dcf3c0ad-9eb8-4ee7-96df-d0db7ff23175 | 2022-08-17 | Boxed warning, Warnings, Adverse reactions | 63323-464 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.